AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OnKure Therapeutics, Inc. Director's Dealing 2021

May 26, 2021

34730_dirs_2021-05-26_a3154424-9daa-47d1-8338-64f2b24d689b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Reneo Pharmaceuticals, Inc. (RPHM)
CIK: 0001637715
Period of Report: 2021-04-08

Reporting Person: Harrison Kenneth Ph.D. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$		Common Stock ()	0	Direct

Footnotes

F1: On April 12, 2021, the reporting person mistakenly filed a Form 4 reporting a grant of a stock option (right to buy) of 14,000 shares that did not in fact occur.